Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGGT1B | P53609 | 8/20 | 0.55 |
| ▸ | FNTA | P49354 | 8/20 | 0.55 |
| ▸ | FNTB | P49356 | 8/20 | 0.55 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7572471 | 0.81 | FNTA (0.54) | PGGT1BFNTAFNTB | |
| Hydrochloric Acid SCHEMBL7569980 | 0.80 | FNTA (0.53) | PGGT1BFNTAFNTB | |
| SCHEMBL7593867 | 0.78 | RBP4 (0.43) | PGGT1BFNTAFNTB | |
| SCHEMBL7090717 | 0.77 | PGGT1B (0.55) | PGGT1BFNTAFNTB | |
| SCHEMBL7087894 | 0.75 | PGGT1B (0.83) | PGGT1BFNTAFNTB | |
| SCHEMBL7221989 | 0.75 | CYP11B2 (0.46) | PGGT1BFNTAFNTB | |
| SCHEMBL7571265 | 0.75 | FNTA (0.44) | PGGT1BFNTAFNTB | |
| SCHEMBL15201578 | 0.75 | FNTA (0.44) | PGGT1BFNTAFNTB | |
| Hydrochloric Acid SCHEMBL7570226 | 0.74 | PGGT1B (0.82) | PGGT1BFNTAFNTB | |
| SCHEMBL7571142 | 0.74 | PGGT1B (0.71) | PGGT1BFNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | ABBOTT LABORATORIES | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | FNTA, FNTB, SLC10A1 | PGGT1B 16/4885FNTA 1/4885FNTB 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.